Special Section: Cancer Moonshot – Five Years and Rising
Oncology Articles Published in Global Forum 2020-2022
February 2020
Immunogenic Cell Death: Bench Comes to Bedside…With Caveats
J. Milburn Jessup
May 2020
Changing the Game in Oncology Development
DIA Global Oncology Development 2020
Eri Sekine
July 2020
Improving Access to CAR T Therapy: It’s Not Just Payment
Michael Kolodziej, Ira Klein, Marc Samuels
September 2020
Accelerating the Pace of Oncology Clinical Trials in the Wake of COVID-19
Vera Mucaj, Ingrid Oakley-Girvan
January 2021
Found in Translation: A Tumultuous Year in Review
G. Kelloff, D. Parkinson
January 2021
Proceedings DIA China 2020: China’s New Cancer Ecosystem Evolves to Address Patients’ Needs and Expectations
Iris Zhu
February 2021
Cancer Immunotherapy: Successes and Challenges on the Bumpy Route from Scientific Concept to Clinical Reality
Part 1: Cancer Immunotherapy as a Novel Promising Treatment Option
Alessandra Cesano
March 2021
Cancer Immunotherapy: Successes and Challenges on the Bumpy Route from Scientific Concept to Clinical Reality
Part 2: Navigating the Road Ahead
Alessandra Cesano
April 2021
Advancing Precision Oncology: TADRUCA, A Model for Global Collaboration
Susan Halabi, Pam Mangat, Elizabeth Garrett-Mayer, Hanneke van der Wijngaart, Henk M. W. Verheul, Emile E. Voest, Lillian Siu, Daniel J. Renouf, Janet Dancey, Richard L. Schilsky
May 2021
Non-Small Cell Lung Cancer: A Bellwether of Progress in Targeted Therapies in Oncology
Siraj M. Ali, Vincent A. Miller
June 2021
Patient-Focused Initiatives in Oncology: How the US Government Paved the Way
Vishal Bhatnagar, Lori Minasian, Paul G. Kluetz
July 2021
I-SPY 2.2: Evolving the I-SPY 2 TRIAL to Adapt Therapies for Each Patient and Optimize Outcome
Laura Esserman, Angela DeMichele, W. Fraser Symmans, Laura van’t Veer, Doug Yee, Denise Wolf, Christina Yau, Nola Hylton
August 2021
Cancer Growth Kinetics Inform the Design of Chemotherapy Regimens
Joshua Z. Drago, Larry Norton
August 2021
Meeting Highlights: DIA China 2021: Cancer Clinical Trial Sites Moving Globalization and Professional Development Forward
Wu Dawei
September 2021
Implication of Cancer Growth Kinetics for the Further Development of Antibody-Drug Conjugates
Joshua Z. Drago, Larry Norton
September 2021
Commentary: The Impact of FDA’s Draft Guidance for Oncology Patient-Reported Outcomes on Future Trial Design
Bill Byrom, Jill Platko, Anthony Everhart
October 2021
Tackling Prostate Cancer with Increasing Precision
William G. Nelson
October 2021
Digital Biomarkers to Improve Quality of Life in Cancer Patients
Moonshot-Funded Decentralized Clinical Research Aims to Better Capture Effects of Cancer Therapy
Ingrid Oakley-Girvan, Reem Yunis
January 2022
Liquid Biopsy and Precision Medicine in Oncology
Caroline C. Sigman, David R. Parkinson, Gary J. Kelloff
January 2022
Advanced Tests and Therapies Making Daily Care Anything But Routine
Gary Kelloff, David Parkinson
February 2022
Is It Time to Screen for and Treat Early Multiple Myeloma?
Irene M. Ghobrial, Ilan “Lanny” Kirsch
February 2022
Oncology: Surprising Therapeutic Area Ripe for Decentralized Research
Candice Del Rio
March 2022
“Digital Oncology”–Wearable and Remote Monitoring Devices for Cancer Treatment and Survivorship
Christopher M. Hartshorn, Michael G. Espey
April 2022
Immunogenic Cell Death Can Overcome Resistance to Checkpoint Inhibitors
J. Milburn Jessup